Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
We have hypothesized that the c-myc oncogene might promote DNA amplification. Resistance to methotrexate (MTX), a widely used cancer chemotherapeutic agent, often results from amplification of the gene coding for the target enzyme, dihydrofolate reductase (DHFR). We report here that gratuitously induced expression of c-myc in rat fibroblasts grown in the presence of MTX greatly increases the number of colonies resistant to the drug. This effect is not related to an alteration of cell growth, and it can also be observed to a lesser extent when c-myc is induced prior to selection in MTX. The DHFR gene is amplified in nearly half of the colonies cultured under selection conditions. Given the likely role of the c-myc product in DNA replication, these results strongly suggest that expression of c-myc plays a role in methotrexate resistance by promoting DNA amplification.
Denis
N
N
Biologie Moléculaire des Cellules Eucaryotes (CNRS URA 1147), Institut Cochin de Génétique Moléculaire, Paris, France.
Kitzis
A
A
Kruh
J
J
Dautry
F
F
Corcos
D
D
D000818:Animals; D002478:Cells, Cultured; D004247:DNA / Q000235:genetics; D004261:DNA Replication; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance / Q000235:genetics; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005784:Gene Amplification / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D015870:Gene Expression; D008727:Methotrexate / Q000494:pharmacology*; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000502:physiology*; D051381:Rats; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics* / Q000378:metabolism
D016271:Proto-Oncogene Proteins c-myc; D004247:DNA; D013762:Tetrahydrofolate Dehydrogenase; D008727:Methotrexate